Valuation (79%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 12.70 | 13.52 |
PEG Ratio (TTM) | 1.15 | 0.92 |
P/S Ratio (TTM) | 1.94 | 2.59 |
P/B Ratio (TTM) | 1.15 | 1.78 |
P/FCF Ratio (TTM) | 7.57 | 10.26 |
Price to 5YR AVG Earnings Ratio | 11.32 | 13.76 |
Price to 5YR AVG FCF Ratio | 10.29 | 7.64 |
Profitability (30%) |
Company | Industry |
---|---|---|
ROA (TTM) | 0.80% | 9.52% |
ROE (TTM) | 9.21% | 9.28% |
Net Profit Margin (TTM) | 15.40% | 15.95% |
ROIC 5YR AVG | 18.73% | 19.98% |
Growth (77%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 22.41% | 26.18% | 13.20% |
Revenue | 10.85% | 7.43% | 10.13% |
Net Income | 21.11% | 23.78% | 11.63% |
Cash Flow | 33.99% | 4.02% | 5.91% |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.04 | 2.75 |
Quick Ratio (TTM) | 0.16 | 4.24 |
D/E Ratio (TTM) | 0.81 | 1.35 |
Interest Coverage (TTM) | 1.51 | 0.70 |
Piotroski F-Score | 6 | 6 |
Altman Z-Score | N/A | 0.30 |
LTL to 5YR AVG FCF | 6.09 | 6.43 |
Shares Outstanding Growth 5YR AVG | -1.12% | 5.15% |